Clinical diagnostics is a dynamic discipline thus evolution and change are constant. The firms that service the medical field must be efficient, flexible and most importantly cost-effective. Immunostics is keenly aware of these obligations as well as to the commitments that you, the health care professional, make to your patients every day. As we complete our 40th year of operation, Immunostics realizes that your input regarding product performance, technical assistance and customer service is of the utmost importance.
Immunostics offers a broad portfolio of performance-driven diagnostics solutions that provide more effective ways to assist in the diagnosis of disease. We also have the proud distinction of having been chosen as the supplier of products to support the United Kingdom's colorectal cancer screening program for the past 19 years, and it continues to support additional fecal occult blood screening programs throughout the world. Millions of patients have been screened for the early detection of problems associated with colorectal cancer with the objective of detecting early warning signs that should be addressed by the patient's clinician in a timely manner.
Our products offer the right balance of science, technology and practicality across the healthcare continuum to provide healthcare professionals with the vital information they need to deliver better, more personalized healthcare to patients around the globe.
Immunostics's products are focused on oncology, women's health, infectious disease and toxicology. The company's commitment to innovation continues today with a substantial development program focused on these fields. Immunostics products are FDA cleared, CLIA waived and have received strong endorsements from both clinicians and medical product distributors. We wish to extend thanks to our many domestic and international distribution partners as well as to the clinicians, and patients who are the ultimate consumers of our products.